151 related articles for article (PubMed ID: 10820893)
1. Oral contraceptives and cardiovascular risk.
Drug Ther Bull; 2000 Jan; 38(1):1-5. PubMed ID: 10820893
[TBL] [Abstract][Full Text] [Related]
2. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components.
Jick H; Jick SS; Gurewich V; Myers MW; Vasilakis C
Lancet; 1995 Dec; 346(8990):1589-93. PubMed ID: 7500750
[TBL] [Abstract][Full Text] [Related]
3. Modern oral contraceptives and cardiovascular disease.
Rosenberg L; Palmer JR; Sands MI; Grimes D; Bergman U; Daling J; Mills A
Am J Obstet Gynecol; 1997 Sep; 177(3):707-15. PubMed ID: 9322646
[TBL] [Abstract][Full Text] [Related]
4. Estrogen and progestin components of oral contraceptives: relationship to vascular disease.
Carr BR; Ory H
Contraception; 1997 May; 55(5):267-72. PubMed ID: 9220222
[TBL] [Abstract][Full Text] [Related]
5. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
[TBL] [Abstract][Full Text] [Related]
6. Venous thromboembolism and desogestrel- or gestodene-containing combination oral contraceptives: what are the facts?
Contracept Rep; 1996 Apr; 7(1):3-6. PubMed ID: 12320047
[TBL] [Abstract][Full Text] [Related]
7. Oral contraceptives and venous thromboembolic disease: the findings from database studies in the United Kingdom and Germany.
Farmer RD; Lawrenson RA
Am J Obstet Gynecol; 1998 Sep; 179(3 Pt 2):S78-86. PubMed ID: 9753314
[TBL] [Abstract][Full Text] [Related]
8. Newer oral contraceptives and the risk of venous thromboembolism.
Walker AM
Contraception; 1998 Mar; 57(3):169-81. PubMed ID: 9617533
[TBL] [Abstract][Full Text] [Related]
9. The new era in oral contraception: pills containing gestodene, norgestimate, and desogestrel.
London RS
Obstet Gynecol Surv; 1992 Nov; 47(11):777-82. PubMed ID: 1436906
[TBL] [Abstract][Full Text] [Related]
10. Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel.
Jick SS; Kaye JA; Russmann S; Jick H
Contraception; 2006 Jun; 73(6):566-70. PubMed ID: 16730485
[TBL] [Abstract][Full Text] [Related]
11. Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
Lancet; 1995 Dec; 346(8990):1582-8. PubMed ID: 7500749
[TBL] [Abstract][Full Text] [Related]
12. Smoking and use of oral contraceptives: impact on thrombotic diseases.
Lidegaard O
Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 2):S357-63. PubMed ID: 10368521
[TBL] [Abstract][Full Text] [Related]
13. Gestodene. A review of its pharmacology, efficacy and tolerability in combined contraceptive preparations.
Wilde MI; Balfour JA
Drugs; 1995 Aug; 50(2):364-95. PubMed ID: 8521763
[TBL] [Abstract][Full Text] [Related]
14. Department of health changes advice on third generation pills.
Mayor S
BMJ; 1999 Apr; 318(7190):1026. PubMed ID: 10205088
[TBL] [Abstract][Full Text] [Related]
15. Thrombotic diseases in young women and the influence of oral contraceptives.
Lidegaard O
Am J Obstet Gynecol; 1998 Sep; 179(3 Pt 2):S62-7. PubMed ID: 9753312
[TBL] [Abstract][Full Text] [Related]
16. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen.
Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Büller HR; Vandenbroucke JP
Lancet; 1995 Dec; 346(8990):1593-6. PubMed ID: 7500751
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular disease and combined oral contraceptives: reviewing the evidence and balancing the risks.
Farley TM; Meirik O; Collins J
Hum Reprod Update; 1999; 5(6):721-35. PubMed ID: 10652981
[TBL] [Abstract][Full Text] [Related]
18. Do different brands of oral contraceptives differ in their effects on cardiovascular disease?
Crook D
Br J Obstet Gynaecol; 1997 May; 104(5):516-20. PubMed ID: 9166189
[TBL] [Abstract][Full Text] [Related]
19. Recent oral contraceptive use patterns in four European countries: evidence for selective prescribing of oral contraceptives containing third-generation progestogens.
van Lunsen HW
Eur J Contracept Reprod Health Care; 1996; 1(1):39-45. PubMed ID: 9678136
[TBL] [Abstract][Full Text] [Related]
20. Effect of 1995 pill scare on rates of venous thromboembolism among women taking combined oral contraceptives: analysis of general practice research database.
Farmer RD; Williams TJ; Simpson EL; Nightingale AL
BMJ; 2000 Aug 19-26; 321(7259):477-9. PubMed ID: 10948026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
